Bone-Modifying Agents in Patients With High-Risk Metastatic Castration-Sensitive Prostate Cancer Treated With Abiraterone Acetate Citation: Fukuokaya W, Mori K, Urabe F, et al. JAMA Netw Open. 2024 Mar 4;7(3):e242467. PMID: 38488793; PMCID: PMC10943414.
The YODA Project